Shinya Goto: JCS/JPCPHS 2025 Guideline Now Available in English
Shinya Goto, Director and Chairman in Metabolic Disease Research Center, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Circulation Journal, adding:
“Publication of JCS/JPCPHS 2025 Guideline on Pulmonary Hypertension and Pulmonary Embolism or Deep Vein Thrombosis.
Good thing for you is that our guideline is now available in English!”
Title: JCS/JPCPHS 2025 Guideline on Pulmonary Hypertension and Pulmonary Embolism/Deep Vein Thrombosis
Authors: Yuichi Tamura, Kenya Kusunose, Yugo Yamashita, Teiji Akagi, Masanori Atsukawa, Yoshihiro Fukumoto, Ayumi Goda, Shinya Goto, Masaru Hatano, Masataka Ikeda, Keiichi Ishida, Masaharu Kataoka, Masataka Kuwana, Hiromi Matsubara, Makoto Mo, Tetsutaro Nagaoka, Takeshi Ogo, Yoshinori Okada, Seiichiro Sakao, Hirofumi Sawada, Toshiro Shinke, Nobuhiro Tanabe, Norikazu Yamada, Hiroyuki Yamagishi, Shingo Yano, Kohtaro Abe, Shiro Adachi, Kazuya Hosokawa, Nobutaka Ikeda, Takumi Inami, Masahiro Jinzaki, Masaru Kato, Takeshi Kitai, Shigetoyo Kogaki, Jun Koizumi, Yoshiteru Morio, Mari Nishizaki, Yoshito Ogihara, Keiko Ohta-Ogo, Kunihiro Shigematsu, Koichiro Sugimura, Yudai Tamura, Yu Taniguchi, Ichizo Tsujino, Keiko Uchida, Takeshi Yamamoto, Atsushi Yao, Nobuhiro Yaoita, Noriaki Emoto, Hiroaki Kitaoka, Mashio Nakamura, Hitoshi Ogino, Toru Satoh, Hiroshi Watanabe
More posts featuring Shinya Goto on Hemostasis Today.
-
Sep 3, 2026, 11:21Thrombotic Microangiopathies: From Clinical Syndrome to Molecularly Targeted Therapy
-
Sep 3, 2026, 10:56Elias Othman: Can an Enzyme Involved in Cell Signaling Become a Target for Antithrombotic Drug Discovery?
-
Sep 3, 2026, 10:42Jared Griffard: Hemorrhagic Shock and Component Blood Transfusion
-
Sep 3, 2026, 10:31Alan Nurden: Comparing Antiplatelet and Antithrombin Therapies in Coronary Microcirculation
-
Sep 3, 2026, 08:53Jamie’s Journey Through a Decade with Immune Thrombocytopenia – ITP Support Association
-
Sep 3, 2026, 08:00Beth Meneley: When Transfusion Is Not an Option – HBOT for Exceptional Blood Loss Anemia
-
Sep 3, 2026, 06:27Seyed Mehrab Safdari: Unmasking Factor VII Padua to Prevent Unnecessary Therapy and Thrombotic Risk
-
Sep 3, 2026, 04:09Pedro Perez: Are We Entering a New Era in the Treatment of Intermediate-High-Risk PE?
-
Sep 3, 2026, 04:01Marianne Yee: Supporting Families and Transformative Therapies in Sickle Cell Disease